Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
Authors
Keywords
Cancer vaccine, Multiple peptides, Prognosis, Non-small cell lung cancer
Journal
Journal of Translational Medicine
Volume 11, Issue 1, Pages 97
Publisher
Springer Nature
Online
2013-04-12
DOI
10.1186/1479-5876-11-97
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: A Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders
- (2012) J. Bae et al. CLINICAL CANCER RESEARCH
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Features Associated with Survival in Metastatic Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines
- (2011) Robert O. Dillman et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight
- (2011) Ji Hye Min et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
- (2011) Susanna V. Ulahannan et al. CANCER INVESTIGATION
- Vaccines for Colorectal Cancer and Renal Cell Carcinoma
- (2011) Katherine Kabaker et al. CANCER JOURNAL
- Immunotherapy for Non-small Cell Lung Cancer: Novel Approaches to Improve Patient Outcome
- (2011) Frances A. Shepherd et al. Journal of Thoracic Oncology
- Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
- (2011) Elisabeth Quoix et al. LANCET ONCOLOGY
- Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer
- (2010) Kyung A Kwon et al. BMC CANCER
- Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer
- (2010) Marta Łukaszewicz-Zając et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
- (2009) Koji Kono et al. CANCER SCIENCE
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Toxicity of Targeted Therapy in Non–Small-Cell Lung Cancer Management
- (2009) Serena Ricciardi et al. Clinical Lung Cancer
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer
- (2009) Yoshiki Shigematsu et al. LUNG CANCER
- A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
- (2008) Lisa H Butterfield et al. Journal of Translational Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started